A. Wittek

发表

Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.

C. Prober, A. Arvin, A. Yeager, 1986 .

Safety and immunogenicity of an HLA‐based HIV envelope polyvalent synthetic peptide immunogen

B. Haynes, J. Bartlett, C. Tacket, 1998 .

Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasma

J. Epstein, A. Wittek, G. Quinnan,, 1986, Transfusion.

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

R. Karron, M. Eichelberger, R. Chanock, 2000, The Journal of infectious diseases.

Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.

R. M. Hendry, D. Shepp, A. Wittek, 1988, The Journal of infectious diseases.

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.

B. Haynes, J. Bartlett, C. Tacket, 1998, AIDS.

Mixed bacterial meningitis in a 4-year-old girl.

Y. Leo, A. Wittek, K. Chokephaibulkit, 1995, The Western journal of medicine.

Immunologic evidence of reinfection with varicella-zoster virus.

A. Arvin, A. Wittek, C. Koropchak, 1983, The Journal of infectious diseases.

Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cells

G. Martin, E. Thompson, A. Wittek, 1988, Journal of cellular biochemistry.

Elevated plasma levels of limulus amoebocyte lysate-reactive material.

D. Rossignol, A. Wittek, M. Lynn, 2006, The Journal of infectious diseases.

Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.

C. Prober, A. Arvin, A. Yeager, 1986, The New England journal of medicine.

Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.

A. Arvin, A. Wittek, P. Palumbo, 1984, The Journal of general virology.

Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.

C. Grose, A. Arvin, A. Wittek, 1986, Journal of immunology.

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

J. Manischewitz, A. Wittek, G. Quinnan,, 1990, Antimicrobial Agents and Chemotherapy.

Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.

A. Nesburn, A. Wittek, H. Ghiasi, 2007, Investigative ophthalmology & visual science.

Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children.

A. Wittek, I. Srugo, P. Brunell, 1993, American journal of diseases of children.

Asymptomatic shedding of herpes simplex virus from the cervix and lesion site during pregnancy. Correlation of antepartum shedding with shedding at delivery.

A. Yeager, P. Hensleigh, D. Au, 1984, American journal of diseases of children.

Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro

E. De Clercq, S. D. Smith, A. Arvin, 1983, Antimicrobial Agents and Chemotherapy.

Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.

M. Amylon, A. Arvin, A. Wittek, 1984, The Journal of pediatrics.

Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.

M. Amylon, A. Arvin, A. Wittek, 1984, The American journal of medicine.

Human monoclonal antibodies neutralizing varicella-zoster virus.

E. Engleman, S. Foung, D. Fishwild, 1985, The Journal of infectious diseases.

Inactivation of human T‐cell lymphotropic virus, type III by heat, chemicals, and irradiation

R. Purcell, J. Epstein, A. Wittek, 1986, Transfusion.

Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status.

R. M. Hendry, A. Wittek, L. Krilov, 1989, Clinical immunology and immunopathology.

Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

S. Opal, A. Wittek, M. Tidswell, 2010, Critical care medicine.

Propagation and properties of Kaposi's sarcoma-derived cell lines obtained from patients with AIDS: similarity of cultured cells to smooth muscle cells.

A. Albini, G. Martin, I. Levenbook, 1991, AIDS.

AIDS, blood transfusions, and directed donations.

A. Wittek, G. Quinnan,, M. Phelan, 1986 .

More on partitioning and inactivation of AIDS virus in immune globulin preparations.

A. Wittek, J. Epstein, G. Quinnan,, 1986, The New England journal of medicine.

Meningoencephalitis in a neonate congenitally infected with human immunodeficiency virus type 1.

A. Wittek, P. Brunell, V. Israele, 1992, The Journal of pediatrics.

Phase 2 trial of eritoran tetrasodium ( E 5564 ) , a Toll-like receptor 4 antagonist , in patients with severe sepsis *

S. Opal, A. Wittek, M. Tidswell, 2009 .

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion.

H. Lane, J. Epstein, A. Wittek, 1987, Annals of internal medicine.

First-time manifestation of generalized Wegener's granulomatosis despite methotrexate.

A. Wittek, H. Nüsslein, L. Unger, 1998, British journal of rheumatology.

Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects

A. Arvin, A. Wittek, C. Koropchak, 1983, Journal of clinical microbiology.

Elevated plasma levels of limulus amoebocyte lysate- reactive material. Authors' reply

C. Natanson, P. Eichacker, D. Rossignol, 2006 .